Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
Objective To investigate the importance of etiological research in clinical therapy of acute retinal necrosis (ARN). Methods Retrospective cases-series study. Analyzed the clinical data of 45 eyes (39 cases) of ARN patients who were diagnosised in the Department of Ophthalmology of PUMCH during January 1996 to December 2012. All patients underwent routine eye examination. Blood samples were taken from 39 patients for serum TORCH test, 22 patients underwent total serum IgG detection. 15 eyes underwent the TORCH and total IgG detection of vitreous humor. The control group: 15 patients (15 eyes) underwent vitrectomy surgery for non-infectious retinal disease during June 2006 to November 2008 in PUMCH. During the process of operation, venous blood and vitreous humor was drawn for the total IgG and the TORCH test respectively. Data were analyzed using independent t test. Results The total IgG results of control group patients′ was 10.02±2.69 g/L, and was 10.10±2.38 g/L in ARN group. The difference was not statistically significant. The Vitreous humor total IgG of control group was 135.3±178.0 mg/L. HSV-IgG and CMV-IgG was detected in the vitreous humor of 15 eyes, the average value of the total IgG of vitreous humor was 2 949.2±1 845.1 mg/L. The difference between vitreous humor total IgG was statistically significant (t=6.024, P<0.01). The Geometric mean titer (GMT) of blood serum HSV in control group was: 86.10±62.02, and the GMT in ARN group was: 86.30±65.31. The difference between two antibodies′ GMT was not statistically significant. Among GWC values of ARN group, the GWC values of 7 eyes in HSV>6, the value suggested the pathogens was HSV. Conclusion The pathogens were suggested by the detection of specific antibodies to the virus in vitreous humor. The treatment for the cause can improve the therapy of ARN.
Urayama A, Yamada N, Sasaki T, et al. Unilateral acute uveitis with periarteritis and detachment[J]. Jpn J Clin Ophthalmol,1971,25:607-619.
[2]
Holland GN. Standard diagnostic criteria for the acute necrosis syndrome[J]. Am J Ophthalmol,1994,117(5):663-667.
[3]
Morlet N, Young S, Naidoo D, et al. High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration[J]. Br J Ophthalmol,1996,80(3):214-216.
[4]
Frau E, Dussaix E, Offret H, et al. The possible role of herpes viruses in multifocal choroiditis and panuveitis[J]. Int Ophthalmol,1990,14(5-6):365-369.
[5]
Klein A, Lefebvre P. Three concecutive episodes retinal necrosis due to herpes simplex-1 over twelve years following herpetic encephalitis[J]. Ocul Immnol Inflamm,2007,15(5):411-413.
[6]
Falcone PM, Brockhurst RJ. Delayed onset of bilateral acute retinal necrosis syndrome: a 34-year interval[J]. Ann Ophthalmol, 1993,25(10):373-374.
[7]
Pavesio CE, Conrad DK, McCluskey PJ, et al. Delayed acute retinal necrosis after herpetic encephalitis[J]. Br J Ophthalmol,1997,81(5):415-416.
[8]
Kamel OR, Galloway GD, Trew DR. Delayed onset acute necrosis 20 years following herpes encephalitis[J]. Eye (Lond),2000,14(Pt 5):788-789.
[9]
Vandercam T, Hintzen RQ, de Boer JH, etal. Herpetic encephalitis is a risk factor for acute retinal necrosis[J]. Neurology,2008,71(16):1268-1274.
[10]
McGrath L, Woods M, Lee L, et al. Acute retinal necrosis (ARN) in the context of neonatal HSV-2 exposure and subconjunctival dexamethasone: case report and literature review[J]. Digit J Ophthalmol,2013,19(2):28-32.
[11]
Muthiah MN, Michaelides M, Child CS, et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK[J]. Br J Ophthalmol,2007,91(11):1452-1455.
[12]
Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes[J]. Ophthalmology,2007, 114(4):756-762.
[13]
Moesen I, Khemka S, Ayliffe W. Aucte retinal necrosis secondary to herpes simplex virus type 2 with preexisting chorioretinal scarring[J]. J Pediatr Ophthalmol Strabismus,2008,45(1):59-61.
[14]
Jeon S, Kakizaki H, Lee WK, et al. Effect of prolonged oral acyclovir treatment in acute retinal necrosis[J]. Ocul Immunol Inflamm,2012,20(4):288-292.
[15]
Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (An American Ophthalmological Society Thesis)[J]. Trans Am Ophthalmol Soc,2013,111:133-144.
[16]
Matsuo T. Timing of prophylactic and early vitrectomy for first-presenting or recurrent acute retinal necrosis syndrome[J]. Acta Med Okayama,2012,66(6):493-497.
[17]
Kijlstra A, van den Horn GJ, Luyendijk L, et al. Laboratory tests in uveitis. New developments in the analysis of local antibody production[J]. Doc Ophthalmol,1990,75(3-4):225-231.
[18]
Kijlstra A. The value of laboratory testing in uveitis[J]. Eye (Lond),1990,4(Pt5):732-736.
[19]
Usui M, Hasemi M, Onishi Y, et al. Electron microscopic study and biochemical analysis on the vitrous of uveitis: Two cases of kirasawa′s uveitis[J]. Jpn Clin Ophthalmol,1984,38:381-387.
[20]
Kaplan HJ, Waldrep JC. Immunologic insights into uveitis and retinitis: the immunoregulatory circuit[J]. Ophthalmology,1984, 91(6):655-665.
[21]
Culbertson WW, Blumenkranz MS, Pepose JS, et al. Varicella zostervirus is a cause of the acute retinal necrosis syndrome[J]. Ophthalmology,1986,93(5):559-569.